Tag: Prescription Drugs
Weekly Dupilumab Beneficial in Eosinophilic Esophagitis
More patients receiving dupilumab have histologic remission, improvement in Dysphagia Symptom Questionnaire scores
FDA Approves Gene Therapy for Tough-to-Treat Bladder Cancer
About 57,000 men and 18,000 women are diagnosed with bladder cancer annually
Metformin Use Linked to Lower Risk for Joint Replacement in T2DM
Reduced risk seen for total knee replacement and total hip replacement with metformin use
ASH: Glofitamab Aids Relapsed, Refractory Diffuse Large B-Cell Lymphoma
39 percent of patients had a complete response, with median time to complete response of 42 days
Sublingual Buprenorphine/Naloxone Tied to More Adverse Dental Outcomes
More adverse dental outcomes seen with sublingual buprenorphine/naloxone compared with use of transdermal buprenorphine or oral naltrexone
Rocatinlimab Effective for Moderate-to-Severe Atopic Dermatitis
Lasting improvement seen for patients receiving anti-OX40 antibody rocatinlimab compared with placebo
Drop in Mortality Seen With AChEI, Memantine in Dementia With Lewy Bodies
Risk for death, unplanned hospital admission significantly lower for those taking AChEIs only or taking AChEIs and memantine
SABCS: Interrupting Endocrine Therapy Does Not Pose Breast Cancer Recurrence Risk
Findings seen among young women with early-stage, hormone receptor-positive breast cancer desiring pregnancy
USPSTF Recommends PrEP for Reducing Risk for HIV Acquisition
Preexposure prophylaxis recommended for adolescents and adults at increased risk for acquiring HIV infection
Risk-Reducing Medications Can Cut Breast Cancer Death Rates
Tamoxifen with annual screening reduced invasive breast cancers and breast cancer deaths by 40 and 57 percent, respectively
